Please login to the form below

Not currently logged in
Email:
Password:

Immunology

This page shows the latest Immunology news and features for those working in and with pharma, biotech and healthcare.

New data keeps AbbVie’s star pipeline therapies on track

New data keeps AbbVie’s star pipeline therapies on track

The company has always insisted however that it’s tight R&D focus on two key areas – immunology and oncology – will deliver the pipeline assets needed to keep it growing.

Latest news

More from news
Approximately 8 fully matching, plus 179 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Back in June 2015 Celgene and Juno announced a ten-year collaboration to combine their respective immunology expertise to develop new immunotherapies for cancer and autoimmune diseases based on T cell

  • The good, the bad and the ugly The good, the bad and the ugly

    selling drug until its patent expiry in the US in 2023, ”says Alexandra Annis, senior analyst, immunology, GlobalData. ... The immunology market has seen setbacks too, with sales at both Pfizer (-3.6%) and Amgen (-10.8%) notably declining.

  • Digital disruption Digital disruption

    Clearly these aren’t isolated examples. Pfizer has teamed up with IBM to accelerate its search for immunology treatments, hoping to identify new drug treatments.

  • Taking a lean and careful approach Taking a lean and careful approach

    with a promising pipeline across multiple programmes for oncology and immunology.

  • Deal Watch November 2016 Deal Watch November 2016

    malignancies. As with PD-1 and other checkpoints, TAMs regulate the immune response to cancer and therefore TAMs have broad application and potential across immuno-oncology and immunology.

More from intelligence
Approximately 3 fully matching, plus 30 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 67 partially matching documents found.

Latest from PMHub

  • PRMA Consulting Ltd

    Our experience encompasses a wide range of indications, including; cardiovascular and renal, gastroenterology, immunology, infectious diseases and vaccines, metabolism and endocrinology, neurology and psychiatry, oncology/hematology, ophthalmology,

  • Hanson Zandi

    Allergy Therapeutics - Allergy products. CSL Behring - Corporate, Critical care, Immunology.

  • Biotech: it's a people business

    From Johnson &Johnson’ s immunology treatments to Pfizer’ s work on a stem cell-based remedy for age-related macular degeneration, pharma companies are quickly realising biotechnology is the future of

  • Perspective on biotech

    Perspective on biotech. In this supplementary issue of Perspective, we reveal the emerging technologies taking the biotech world by storm and ask if the definition of a biotech organisation needs updating. Biotech companies operate in highly complex

  • TVF Communications shortlisted for the Writing Excellence award at Communique 2016

    TVF Communications shortlisted for the Writing Excellence award at Communique 2016. TVF Communications; an independent, global healthcare communications agency, has been shortlisted for the Writing Excellence – Digital / Online Content Award at

More from PMHub
Approximately 3 fully matching, plus 21 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics